Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors

Drug Metabolism and Disposition

Volumn 35, Issue 4, 2007, Pages 595-601

  Evseenko, Denis A ^a   Paxton, James W ^b   Keelan, Jeffrey A ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; DRUG CARRIER; DRUG METABOLITE; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOXANTRONE; MULTIDRUG RESISTANCE GENE PRODUCT 3; MULTIDRUG RESISTANCE PROTEIN 1; PROGESTERONE; SOMATOMEDIN B; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TROPHOBLAST;

ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CYTOKINES; DIGOXIN; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MITOXANTRONE; PEPTIDE FRAGMENTS; PLACENTA; PREGNANCY; PROGESTERONE; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34047162390     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.011478     Document Type: Article

References (43)

1. Barreca A, Bozzola M, Cesarone A, Steenbergh PH, Holthuizen PE, Severi F, Giordano G, and Minuto F (1998) Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy. J Clin Endocrinol Metab 83:3534-3541.
2. Batra S and Bengtsson LP (1978) 17 beta-Estradiol and progesterone concentrations in myometrium of pregnancy and their relationships to concentrations in peripheral plasma. J Clin Endocrinol Metab 46:622-626.
3. Belliard AM, Lacour B, Farinotti R, and Leroy C (2004) Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J Pharm Sci 93:1524-1536.
4. Blumenstein M, Keelan JA, and Mitchell MD (2001) Hypoxia attenuates PGE(2)but increases prostacyclin and thromboxane production in human term villous trophoblast. Placenta 22:519-525.
5. Ceckova M, Libra A, Pavek P, Nachtigal P, Brabec M, Fuchs R, and Staud F (2006) Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin Exp Pharmacol Physiol 33:58-65.
6. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, et al. (2002) Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature (Lond) 417:945-948.
7. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, and Rice GE (2001) Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 18:921-927.
8. Ee PL, He X, Ross DD, and Beck WT (2004) Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference. Mol Cancer Ther 3:1577-1583.
9. Ernst M, Schmid C, and Froesch ER (1989) Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. J Steroid Biochem 33:907-914.
10. Evseenko DA, Paxton JW, and Keelan JA (2006a) ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290:R1357-R1365.
11. Evseenko DA, Paxton JW, and Keelan JA (2006b) Transport across the placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol 2:51-69.
12. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, and Taketani Y (1997) Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 38:89-93.
13. Hartmann G, Kim H, and Piquette-Miller M (2001) Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 1:189-199.
14. Inada H, Izawa I, Nishizawa M, Fujita E, Kiyono T, Takahashi T, Momoi T, and Inagaki M (2001) Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J Cell Biol 155:415-426.
15. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, and Steer PJ (2002) Does endothelial cell activation occur with intrauterine growth restriction? BJOG 109:836-839.
16. Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, and Schinkel AH (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651-1656.
17. Khan-Dawood FS and Dawood MY (1984) Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy. Am J Obstet Gynecol 150:501-505.
18. Kim YN, Wiepz GJ, Guadarrama AG, and Bertics PJ (2000) Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J Biol Chem 275:7481-7491.
19. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, and Catalano PM (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207-2213.
20. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, and Strauss JF (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567-1582.
21. Lankas GR, Wise LD, Cartwright ME, Pippert T, and Umbenhauer DR (1998) Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12:457-463.
22. Lee G and Piquette-Miller M (2003) Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays. J Pharm Sci 92:2152-2163.
23. Litman T, Druley TE, Stein WD, and Bates SE (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931-959.
24. Luppi P and Deloia JA (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118:268-275.
25. Mathias AA, Hitti J, and Unadkat JD (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289:R963-R969.
26. Morrish DW, Dakour J, and Li H (1998) Functional regulation of human trophoblast differentiation. J Reprod Immunol 39:179-195.
27. Muller C, Laurent G, and Ling V (1995) P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. J Cell Physiol 163:538-544.
28. Nagashige M, Ushigome F, Koyabu N, Hirata K, Kawabuchi M, Hirakawa T, Satoh S, Tsukimori K, Nakano H, Uchiumi T, et al. (2003) Basal membrane localization of MRP1 in human placental trophoblast. Placenta 24:951-958.
29. Pascolo L, Fernetti C, Pirulli D, Crovella S, Amoroso A, and Tiribelli C (2003) Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun 303:259-265.
30. Patel P, Weerasekera N, Hitchins M, Boyd CA, Johnston DG, and Williamson C (2003) Semiquantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 24:39-44.
31. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, and Kimura T (2000) Cytokine production in chorioamnionitis. J Reprod Immunol 47:185-196.
32. Shaarawy M and Nagui AR (1997) Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion. Acta Obstet Gynecol Scand 76:205-211.
33. Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, Varadi A, Sarkadi B, and Borst P (2000) MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem 275:23530-23539.
34. Steinborn A, Niederhut A, Solbach C, Hildenbrand R, Sohn C, and Kaufmann M (1999) Cytokine release from placental endothelial cells, a process associated with preterm labour in the absence of intrauterine infection. Cytokine 11:66-73.
35. St-Pierre MV, Ugele B, Gambling L, and Shiverick KT (2002) Mechanisms of drug transfer across the human placenta - a workshop report. Placenta 23:S159-S164.
36. Sukhai M, Yong A, Pak A, and Piquette-Miller M (2001) Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm Res 50:362-370.
37. Tang W, Yi C, Kalitsky J, and Piquette-Miller M (2000) Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol Cell Biol Res Commun 4:90-97.
38. Unadkat JD, Dahlin A, and Vijay S (2004) Placental drug transporters. Curr Drug Metab 5:125-131.
39. Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, and Mao Q (2006) Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290:E798-E807.
40. Wang JH, Scollard DA, Teng S, Reilly RM, and Piquette-Miller M (2005) Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging. J Nucl Med 46:1537-1545.
41. Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, Salamon F, Turi Z, Kovacs M, Vargha P, et al. (2002) Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 56:93-99.
42. Yashwanth R, Rama S, Anbalagan M, and Rao AJ (2006) Role of estrogen in regulation of cellular differentiation: a study using human placental and rat Leydig cells. Mol Cell Endocrinol 246:114-120.
43. Zu Schwabedissen HE, Grube M, Dreisbach A, Jedlitschky G, Meissner K, Linnemann K, Fusch C, Ritter CA, Volker U, and Kroemer HK (2006) Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of abcg2 (bcrp). Drug Metab Dispos 34:524-533.